Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 101 (4) , S427-S433
- https://doi.org/10.1016/s0091-6749(98)70154-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patientsEuropean Respiratory Journal, 1996
- NO or no NO in asthma?Thorax, 1996
- Transcription factorsClinical and Experimental Allergy, 1995
- Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapyEuropean Respiratory Journal, 1995
- Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?European Respiratory Journal, 1994
- Anti-inflammatory actions of steroids: molecular mechanismsTrends in Pharmacological Sciences, 1993
- Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthmaThe Lancet, 1992
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987